Valuation: Mega Lifesciences

Market Cap 30.52B 915M 802M 739M 692M 1.3B 86.29B 1.32B 8.89B 3.44B 42.64B 3.43B 3.36B 148B P/E 2026 *
13.1x
P/E 2027 * 12.4x
Enterprise Value 25.66B 769M 674M 622M 582M 1.09B 72.57B 1.11B 7.47B 2.89B 35.86B 2.89B 2.83B 124B EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.65x
Free-Float
38.61%
Yield 2026 *
5.07%
Yield 2027 * 5.36%
1 day-0.71%
Current month-2.78%
1 month-0.71%
3 months+2.19%
6 months+7.69%
Current year+4.48%
1 week 34
Extreme 34
35.75
1 month 33.75
Extreme 33.75
36
Current year 31.5
Extreme 31.5
40
1 year 25
Extreme 25
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 61 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap.
29/04/25Buy

Chief Executive Officer

100,000 0.0115%
28/04/25Buy

Chief Executive Officer

50,000 0.0057%
28/04/25Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
-0.71%0.00%+35.92%-3.45% 915M
+7.13%+9.97%+55.80%+160.09% 1,077B
+3.99%+11.50%+67.09%+55.96% 613B
+4.20%+17.03%+38.97%+91.06% 448B
+0.99%+4.85%+28.17%+23.89% 332B
+1.82%+8.19%+40.04%+27.95% 293B
+0.22%+6.75%+31.30%+42.34% 286B
+0.73%+8.53%-27.33%-39.55% 215B
+1.56%+6.14%+29.30%+60.97% 193B
+3.26%+3.33%+15.55%+68.24% 159B
Average +2.32%+7.27%+31.48%+48.75% 361.7B
Weighted average by Cap. +3.85%+8.93%+41.75%+80.15%

Financials

2026 *2027 *
Net sales 14.88B 446M 391M 360M 337M 633M 42.07B 646M 4.33B 1.68B 20.79B 1.67B 1.64B 72.09B 15.61B 468M 410M 378M 354M 664M 44.15B 678M 4.55B 1.76B 21.82B 1.76B 1.72B 75.65B
Net income 2.32B 69.54M 60.97M 56.2M 52.62M 98.67M 6.56B 101M 676M 261M 3.24B 261M 255M 11.24B 2.46B 73.74M 64.65M 59.59M 55.79M 105M 6.96B 107M 716M 277M 3.44B 277M 271M 11.92B
Net Debt -4.85B -145M -128M -118M -110M -206M -13.72B -211M -1.41B -547M -6.78B -546M -534M -23.51B -4.76B -143M -125M -115M -108M -202M -13.45B -206M -1.38B -536M -6.65B -535M -524M -23.05B
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
26/06/26 THB 35.00 -0.71% 1,092,935
25/06/26 THB 35.25 +2.17% 1,113,715
24/06/26 THB 34.50 +0.73% 370,797
23/06/26 THB 34.25 -1.44% 546,634
22/06/26 THB 34.75 -0.71% 1,441,697
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
35.00THB
Average target price
41.14THB
Spread / Average Target
+17.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MEGA Stock